Thyroid dysfunction and hemostasis: An issue still unresolved

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 3, 2009, Pages 288-294

  Franchini, Massimo ^a   Montagnana, Martina ^b   Manzato, Franco ^c   Vescovi, Pier Paolo ^c  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c CARLO POMA HOSPITAL   (Italy)

Author keywords

Bleeding; Hemostasis; Hyperthyroidism; Hypothyroidism; Thrombosis; Thyroid

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; VON WILLEBRAND FACTOR; THYROID HORMONE;

BLEEDING TENDENCY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOSIS; THYROID DISEASE; BLEEDING; BLOOD; BLOOD CLOTTING DISORDER; PHYSIOLOGY;

BLOOD COAGULATION DISORDERS; FIBRINOLYSIS; HEMORRHAGE; HEMOSTASIS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THROMBOSIS; THYROID DISEASES; THYROID HORMONES;

EID: 67649229621     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1222607     Document Type: Review

References (76)

1. Squizzato A, Romualdi E, Bü ller HR, Gerdes VEA. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 2007;92:2415-2420 (Pubitemid 47037335)
2. Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 1965;273:1057-1061
3. Myrup B, Bregengård C, Faber J. Primary haemostasis in thyroid disease. J Intern Med 1995;238:59-63
4. Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997;136:1-7
5. Squizzato A, Gerdes VEA, Ageno W, Büller HR. The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med 2007;2:76-83
6. Franchini M. Hemostasis and thyroid diseases revisited. J Endocrinol Invest 2004;27:886-892
7. Marongiu F, Cauli C, Mariotti S. Thyroid, hemostasis and thrombosis. J Endocrinol Invest 2004;27:1065-1071
8. Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgrad Med J 1990;66:280-284
9. Erem C, Kavgaci H, Ersöz HO, et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 2003; 57:78-81 (Pubitemid 36372557)
10. Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987; 1:1007-1009
11. Thornton JG, Parapia LA, Minford AMB. Hypothyroidism and von Willebrand's disease. Lancet 1987;1:1314-1315
12. Nitu-Whalley IC, Lee CA. Acquired von Willebrand syndrome - report of 10 cases and review of the literature. Haemophilia 1999;5:318-326 (Pubitemid 29495708)
13. Michiels JJ, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001;7:113-115 (Pubitemid 32242186)
14. Attivissimo LA, Lichtman SM, Klein I. Acquired von Willebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid 1995;5:399-401
15. Blesing NE, Hambley H, McDonald GA. Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia. Postgrad Med J 1990;66:474-476 (Pubitemid 20187968)
16. Bruggers CS, McElligott K, Rallison ML. Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy. J Pediatr 1994;125(6 Pt 1):911-913 (Pubitemid 24379125)
17. Levesque H, Borg JY, Cailleux N, et al. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Eur J Med 1993;2:287-288 (Pubitemid 23136613)
18. Aylesworth CA, Smallridge RC, Rick ME, Alving BM. Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis. Am J Hematol 1995;50:217-219
19. Tjan-Heijnen VCG, Harthoorn-Lasthuizen EJ, Kurstjens RMA, Koolen MI. A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease. Neth J Med 1994;44:91-94 (Pubitemid 24089457)
20. Franchini M, de Gironcoli M, Lippi G, et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haemophilia 2002;8:142-144 (Pubitemid 35238068)
21. Franchini M, Zugni C, Veneri D, et al. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 2004;89: 1341-1346 (Pubitemid 39540571)
22. Franchini M, Veneri D, Lippi G. Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels. Thromb Haemost 2005;93:392-393 (Pubitemid 40253754)
23. Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thromb Haemost 1976;35:415-422
24. Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E. Activation of blood coagulation and fibrinolysis in Graves' disease. Horm Metab Res 1991;23:609-611
25. Erem C, Ersöz HO, Karti SS, et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002;25:345-350 (Pubitemid 34436130)
26. Hymes K, Blum M, Lackner H, Karpatkin S. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med 1981;94:27-30 (Pubitemid 11218723)
27. Lamberg BA, Kivikangas V, Pelkonen R, Vuopio P. Thrombocytopenia and decreased life-span of thrombocytes in hyperthyroidism. Ann Clin Res 1971;3:98-102
28. Kurata Y, Nishioeda Y, Tsubakio T, Kitani T. Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. Acta Haematol 1980;63:185-190 (Pubitemid 10116997)
29. Panzer S, Haubenstock A, Minar E. Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. J Clin Endocrinol Metab 1990; 70:491-496 (Pubitemid 20056489)
30. Marshall JS, Weisberger AS, Levy RP. Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann Intern Med 1967;67:411-414
31. Adrouny A, Sandler RM, Carmel R. Variable presentation of thrombocytopenia in Graves' disease. Arch Intern Med 1982;142:1460-1464 (Pubitemid 12048345)
32. Pinals RS, Tomar RH, Haas DC, Farah R. Graves' disease, myasthenia gravis, and purpura. Ann Intern Med 1977; 87:250
33. Yamaguchi K, Ookubo Y, Matsuda H, Suzaki K, Fukushima H, Uzawa H. Idiopathic thrombocytopenic purpura subsequent to Graves' disease and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1987;3:233-237 (Pubitemid 17092559)
34. Lio S, Albin M, Girelli G, et al. Abnormal thyroid function test results in patients with Fisher-Evans syndrome. J Endocrinol Invest 1993;16:163-167 (Pubitemid 23137953)
35. Crabtree GR, Lee JC, Cornwell GG III. Letter: autoimmune thrombocytopenia purpura and Hashimoto's thyroiditis. Ann Intern Med 1975;83:371-372
36. Ho SL, Shah M, Williams AC. Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis. Muscle Nerve 1992;15:966-967
37. Segal BM, Weintraub MI. Hashimoto's thyroiditis, myasthenia gravis, idiopathic thrombocytopenic purpura. Ann Intern Med 1976;85:761-763
38. Cordiano I, Betterle C, Spadaccino CA, Soini B, Girolami A, Fabris F. Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol 1998;113:373-378
39. Hofbauer LC, Spitzweg C, Schmauss S, Heufelder AE. Graves disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med 1997;157:1033-1036 (Pubitemid 27190894)
40. Zeigler ZR, Hasiba U, Lewis JH, Vagnucci AH, West VA, Bezek EA. Hemostatic defects in response to aspirin challenge in hypothyroidism. Am J Hematol 1986;23:391-399 (Pubitemid 17191527)
41. Hellem AJ, Segaard E, Solem JH. The adhesiveness of human blood platelets and thyroid function. Acta Med Scand 1975;197:15-17
42. Edson JR, Fecher DR, Doe RP. Low platelet adhesiveness and other hemostatic abnormalities in hypothyroidism. Ann Intern Med 1975;82:342-346
43. Palareti G, Biagi G, Legnani C, et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 1989; 62:1053-1056 (Pubitemid 20011488)
44. Egeberg BO. Influence of thyroid function on the blood clotting system. Scand J Clin Lab Invest 1963;15:1-7
45. Rogers JS II, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982;97:713-716
46. Rogers JS II, Shane SR. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983;102:444-449
47. Nordoy A, Vik-Mo H, Berntsen H. Haemostatic and lipid abnormalities in hypothyroidism. Scand J Haematol 1976;16: 154-160
48. Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 2005;152:355-361 (Pubitemid 40439487)
49. Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 2001;7:523-525 (Pubitemid 32923262)
50. Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S. Apathetic Graves' disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 2002;25:246-249 (Pubitemid 34295880)
51. Sievert R, Goldstein ML, Surks MI. Graves' disease and autoimmune factor VIII deficiency. Thyroid 1996;6:245-247 (Pubitemid 26279419)
52. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998;79:99-103 (Pubitemid 28037066)
53. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001;86:732-737 (Pubitemid 32207488)
54. Müller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 2001;31:131-137 (Pubitemid 32199906)
55. Marongiu F, Biondi G, Conti M, et al. Is a hypercoagulable state present in hypothyroidism? Thromb Haemost 1992; 67:729
56. Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007;92:3006-3012 (Pubitemid 47236363)
57. Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001;11:153-160 (Pubitemid 32221038)
58. Morikawa Y, Morikawa A, Makino I. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones. J Clin Endocrinol Metab 1993;76:609-614 (Pubitemid 23086474)
59. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-278 (Pubitemid 30106257)
60. O ̈zcan MA, Cömlekçi A, Demirkan F, et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb Res 2003;110:243-247
61. Loeliger EA, Esch B. The biological disappearance rate of prothrombin, factors VII, IX and X from plasma in hypothyroidism, hyperthyroidism and during fever. Thromb Diath Haemorrh 1964;10:267-277
62. Lippi G, Franchini M, Targher G, et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis 2008; September 12 (Epub ahead of print)
63. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 2006;64:323-329
64. Cantürk Z, Cetinarslan B, Tarkun I, Cantürk NZ, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2003;13:971-977 (Pubitemid 37351881)
65. Li Y, Chen H, Tan J, Wang X, Liang H, Sun X. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur J Clin Invest 1998;28:1050-1054 (Pubitemid 29050141)
66. Morishita E, Hashimoto T, Asakura H, et al. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease. Thromb Haemost 1998;79:919-923 (Pubitemid 28224724)
67. Chadarevian R, Bruckert E, Giral P, Turpin G. Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinolysis 1999;10:481-486 (Pubitemid 30013713)
68. Grant PJ, Medcalf RL. Hormonal regulation of haemostasis and the molecular biology of the fibrinolytic system. Clin Sci (Lond) 1990;78:3-11
69. Marongiu F, Conti M, Mameli G, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 1988;11:723-725 (Pubitemid 19009045)
70. Polikar R, Burger AG, Scherrer US, Nicod P. The thyroid and the heart. Circulation 1993;87:1435-1441
71. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992;327:94-98
72. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004;24:1-13 (Pubitemid 41364165)
73. Mariotti S, Cambuli VM. Cardiovascular risk in elderly hypothyroid patients. Thyroid 2007;17:1067-1073 (Pubitemid 350207761)
74. Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 2007;17:1075-1084 (Pubitemid 350207760)
75. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol 2008;125:41-48 (Pubitemid 351305426)
76. Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008;148:832-845 (Pubitemid 351786932)